Turning off the G2 DNA damage checkpoint

DNA Repair

Volumn 7, Issue 2, 2008, Pages 136-140

  Calonge, Teresa M ^a   O'Connell, Matthew J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Checkpoint; Chk1; Protein kinase; Protein phosphatase; Ubiquitin dependent proteolysis

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; APHIDICOLIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CLASPIN; CYCLIN DEPENDENT KINASE; DNA; HISTONE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN; PROTEIN KINASE; PROTEIN RAD9; REPLICATION FACTOR A; SINGLE STRANDED DNA; UBIQUITIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL FATE; CELL FUNCTION; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INHIBITION; EUKARYOTIC CELL; HUMAN; IN VITRO STUDY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; YEAST;

DNA DAMAGE; G2 PHASE; GENE EXPRESSION REGULATION; GENES, CDC; PHOSPHORYLATION; PROTEIN KINASES;

SCHIZOSACCHAROMYCETACEAE;

EID: 37549029237     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2007.07.017     Document Type: Review

References (48)

1. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12 2 (2000) 186-192
2. Michael D., and Oren M. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12 1 (2002) 53-59
3. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 116 2 (2004) 221-234
4. Giono L.E., and Manfredi J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell. Physiol. 209 1 (2006) 13-20
5. O'Connell M.J., Walworth N.C., and Carr A.M. The G2-phase DNA-damage checkpoint. Trends Cell Biol. 10 7 (2000) 296-303
6. O'Connell M.J., and Cimprich K.A. G2 damage checkpoints: what is the turn-on?. J. Cell Sci. 118 Pt 1 (2005) 1-6
7. Paulsen R.D., and Cimprich K.A. The ATR pathway: fine-tuning the fork. DNA Repair (Amst) 6 7 (2007) 953-966
8. Falck J., Coates J., and Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434 7033 (2005) 605-611
9. Smits V.A., Reaper P.M., and Jackson S.P. Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr. Biol. 16 2 (2006) 150-159
10. Raleigh J.M., and O'Connell M.J. The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J. Cell Sci. 113 Pt 10 (2000) 1727-1736
11. Fillingham J., Keogh M.C., and Krogan N.J. GammaH2AX and its role in DNA double-strand break repair. Biochem. Cell Biol. 84 4 (2006) 568-577
12. Unal E., et al. DNA damage response pathway uses histone modification to assemble a double-strand break-specific cohesin domain. Mol. Cell 16 6 (2004) 991-1002
13. Latif C., Elzen N.R., and O'Connell M.J. DNA damage checkpoint maintenance through sustained Chk1 activity. J. Cell Sci. 117 Pt 16 (2004) 3489-3498
14. Cohen P.T. Protein phosphatase 1-targeted in many directions. J. Cell Sci. 115 Pt 2 (2002) 241-256
15. den Elzen N., et al. Resisting arrest: recovery from checkpoint arrest through dephosphorylation of Chk1 by PP1. Cell Cycle 3 5 (2004) 529-533
16. den Elzen N.R., and O'Connell M.J. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J. 23 4 (2004) 908-918
17. Walworth N.C., and Bernards R. rad-Dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 271 (1996) 353-356
18. Lu X., Nguyen T.A., and Donehower L.A. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle 4 8 (2005) 1060-1064
19. Macip S., et al. Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint. Oncogene 25 45 (2006) 6037-6047
20. Leung-Pineda V., Ryan C.E., and Piwnica-Worms H. Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol. Cell. Biol. 26 20 (2006) 7529-7538
21. Verkade H.M., and O'Connell M.J. Cut5 is a component of the UV-responsive DNA damage checkpoint in fission yeast. Mol. Gen. Genet. 260 5 (1998) 426-433
22. Bentley N.J., et al. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J. 15 23 (1996) 6641-6651
23. Keogh M.C., et al. A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature 439 7075 (2006) 497-501
24. Nakamura T.M., et al. Histone H2A phosphorylation controls Crb2 recruitment at DNA breaks, maintains checkpoint arrest, and influences DNA repair in fission yeast. Mol. Cell. Biol. 24 14 (2004) 6215-6230
25. Bassing C.H., et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114 3 (2003) 359-370
26. Sanchez Y., et al. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271 (1996) 357-360
27. Cohen-Fix O., and Koshland D. The anaphase inhibitor of Saccharomyces cerevisiae Pds1p is a target of the DNA damage checkpoint pathway. Proc. Natl. Acad. Sci. USA 94 26 (1997) 14361-14366
28. Pellicioli A., et al. Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest. Mol. Cell 7 2 (2001) 293-300
29. O'Neill B.M., et al. Pph3-Psy2 is a phosphatase complex required for Rad53 dephosphorylation and replication fork restart during recovery from DNA damage. Proc. Natl. Acad. Sci. USA 104 22 (2007) 9290-9295
30. Leroy C., et al. PP2C phosphatases Ptc2 and Ptc3 are required for DNA checkpoint inactivation after a double-strand break. Mol. Cell 11 3 (2003) 827-835
31. Ang X.L., and Wade Harper J. SCF-mediated protein degradation and cell cycle control. Oncogene 24 17 (2005) 2860-2870
32. Zhang Y.W., et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 19 5 (2005) 607-618
33. Kumagai A., and Dunphy W.G. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol. Cell 6 4 (2000) 839-849
34. Yoo H.Y., et al. Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase. Cell 117 5 (2004) 575-588
35. Mamely I., et al. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr. Biol. 16 19 (2006) 1950-1955
36. Peschiaroli A., et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell 23 3 (2006) 319-329
37. Mailand N., et al. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell 23 3 (2006) 307-318
38. Margolis S.S., et al. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J. 22 21 (2003) 5734-5745
39. Coleman T.R., Tang Z., and Dunphy W.G. Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer. Cell 72 (1993) 919-929
40. Kanoh J., and Russell P. The protein kinase Cdr2, related to Nim1/Cdr1 mitotic inducer, regulates the onset of mitosis in fission yeast. Mol. Biol. Cell 9 12 (1998) 3321-3334
41. Parker L.L., et al. Phosphorylation and inactivation of the mitotic inhibitor wee1 by the nim1/cdr1 kinase. Nature 363 (1993) 736-738
42. Wu L., and Russell P. Nim1 kinase promotes mitosis by inactivating Wee1 tyrosine kinase. Nature 363 6431 (1993) 738-741
43. Breeding C.S., et al. The cdr2(+) gene encodes a regulator of G2/M progression and cytokinesis in Schizosaccharomyces pombe. Mol. Biol. Cell 9 12 (1998) 3399-3415
44. Calonge T.M., and O'Connell M.J. Antagonism of Chk1 signaling in the G2 DNA damage checkpoint by dominant alleles of Cdr1. Genetics 174 1 (2006) 113-123
45. Yamada A., et al. DNA replication checkpoint control of Wee1 stability by vertebrate Hsl7. J. Cell Biol. 167 5 (2004) 841-849
46. Asano S., et al. Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeast. EMBO J. 24 12 (2005) 2194-2204
47. Garber K. New checkpoint blockers begin human trials. J. Natl. Cancer Inst. 97 14 (2005) 1026-1028
48. Janetka J.W., et al. Inhibitors of checkpoint kinases: from discovery to the clinic. Curr. Opin. Drug Discov. Dev. 10 4 (2007) 473-486